HST Global plans to develop new Clinical Treatment Facility in Ecuador

HST Global, Inc. (OTCBB: HSTC) today announced that it has targeted Ecuador for development of a Clinical Treatment Facility.

“I am pleased we are now in a position to move forward with our international expansion into Ecuador. As a company, we continue to seek opportunities to mature our corporate strategy and benefit the global community while also serving to substantiate shareholder value.”

As the acceptance of integrative science-based cancer treatments worldwide continues to grow, so has HST Global, Inc.’s strategy of opening our own brand of Cancer Treatment Centers. To further facilitate this approach, HST Global is relying on international markets to reach a worldwide population. HST feels Ecuador will provide a significant platform to benefit patients on a global scale.

Mr. Ron Howell, CEO and President of HST Global Inc., stated, “We are impressed with the demographic diversity and economic infrastructure that Ecuador has developed. They have built world-class facilities that offer cutting edge technologies that complement our clinical protocols. We are in the initial phases of developing our entry strategy for Ecuador through relationships we have developed worldwide. These global partners will allow HST to leverage itself and align its resources in an effort to develop an Ecuadorian facility.”

Wes Tate, CFO, stated “I am pleased we are now in a position to move forward with our international expansion into Ecuador. As a company, we continue to seek opportunities to mature our corporate strategy and benefit the global community while also serving to substantiate shareholder value.”

SOURCE HST Global, Inc.